The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation

Published 2016 View Full Article

Authors

Keywords

Journal

HEALTH TECHNOLOGY ASSESSMENT

Volume 20, Issue 34, Pages 1-222

Publisher

National Institute for Health Research

Online

2016-05-05

DOI

10.3310/hta20340

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

HEALTH TECHNOLOGY ASSESSMENT

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer